APA (7th ed.) Citation

L, L., API, H., JM, v. D., EK, W., JV, v. T., MS, v. d. H., . . . ADR, H. (2024). Treatment patterns and survival outcomes of patients admitted to the intensive care unit due to immune-related adverse events of immune checkpoint inhibitors. Cancer medicine, 13(12), e7302. https://doi.org/10.1002/cam4.7302

Chicago Style (17th ed.) Citation

L, Lin, Houwink API, van Dieren JM, Wolthuis EK, van Thienen JV, van der Heijden MS, Haanen JBAG, Beijnen JH, and Huitema ADR. "Treatment Patterns and Survival Outcomes of Patients Admitted to the Intensive Care Unit Due to Immune-related Adverse Events of Immune Checkpoint Inhibitors." Cancer Medicine 13, no. 12 (2024): e7302. https://doi.org/10.1002/cam4.7302.

MLA (9th ed.) Citation

L, Lin, et al. "Treatment Patterns and Survival Outcomes of Patients Admitted to the Intensive Care Unit Due to Immune-related Adverse Events of Immune Checkpoint Inhibitors." Cancer Medicine, vol. 13, no. 12, 2024, p. e7302, https://doi.org/10.1002/cam4.7302.